Baixar PDF
1 / Páginas

Outros usuários também visualizaram estes artigos

Is dyslipidemia a risk factor for trastuzumab-induced cardiotoxicity in breast cancer patients? A systematic review and meta-analysis Jaime Pinho; Miguel Carvalho; Mariana Paiva; Nuno Teixeira-Tavares; Cristina Costa-Santos; Carla Sousa;
Rev Port Cardiol. 2023;42:961-84
Irbesartan has a curative effect on lipopolysaccharide-induced cardiotoxicity by antioxidant and antiapoptotic pathways Muhammet Yusuf Tepeba¿i; Halil A¿ci; Samet Co¿an; Mehmet Abdülkadir Sevük; Nas¿f Fatih Karakuyu; Özlem Özmen;
Rev Port Cardiol. 2023;42:895-903
Practical approach to referral from primary health care to a cardiology hospital consultation in 2022 Rui Baptista; Tiago Maricoto; Sílvia Monteiro; Jordana Dias; Sara Gonçalves; Helena Febra; Victor Gil;
Rev Port Cardiol. 2023;42:557-78